索通發展(603612.SH):2021年度淨利預增161.59%-180.28%
格隆匯1月21日丨索通發展(603612.SH)公佈2021年年度業績預增公吿,公司預計2021年度實現歸屬於上市公司股東的淨利潤為5.6億元到6億元,同比增加161.59%到180.28%。預計歸屬於上市公司股東的扣除非經常性損益的淨利潤為5.6億元到6億元,同比增加167.45%到186.55%。
業績預增的主要原因:(1)產能規模優勢凸顯,集中化、全球化採購以及內部精益化管理水平的持續提升,使得降本增效成果顯著,單位成本更具競爭力,盈利能力逐步提高;(2)本期預焙陽極銷量較上年度穩步增加;(3)下游需求強勁,預焙陽極行業價格較上年度增幅較高。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.